H. Lee Moffitt Cancer Center and Research Institute: all 539 studies

Page 1 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.

• Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking SmokersNot yet recruitingNCT07754448Not applicable
• Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and OsteosarcomaRecruitingNCT07725380Phase 1/2
• Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMDRecruitingNCT07694986Phase 2
• Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryRecruitingNCT07686250Phase 2
• PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)Not yet recruitingNCT07638150Not applicable
• Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid TumorsRecruitingNCT07487168Phase 1
• Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPCRecruitingNCT07476001Phase 2
• Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer SurvivorsRecruitingNCT07447635Not applicable
• Phase III Trial of Brain MRI Surveillance in Stage IV Breast CancerRecruitingNCT07357298Phase 3
• Development of a Mindfulness-Based Smartphone Application for BMT CaregiversNot yet recruitingNCT07352943Not applicable
• Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal MelanomaRecruitingNCT07276386Phase 2
• Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALLRecruitingNCT07250087Phase 1
• A First-in-Human Study of FID-022 in Solid Tumor PatientsRecruitingNCT07249775
• Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCsRecruitingNCT07222995Not applicable
• Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingNCT07194044Phase 1
• Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)RecruitingNCT07047885Phase 1
• Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic LymphomaRecruitingNCT07030400
• The MIND-BC Study: MIND Diet for Breast Cancer CognitionRecruitingNCT07018986Not applicable
• Pembrolizumab for Advanced Cutaneous Sarcomas Not Including AngiosarcomaRecruitingNCT07007273Phase 2
• Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology AgentsRecruitingNCT06963346Phase 1
• Clinical Trial of CD40L-augmented TIL for Patients With Advanced MelanomaRecruitingNCT06961357Phase 1/2
• Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed MyelomaRecruitingNCT06947083Phase 2
• Phase II Study of Systemic Screening in Pathologic Node Positive Breast CancerRecruitingNCT06833502Phase 2
• Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell LymRecruitingNCT06760156Phase 2
• Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and ScreeningRecruitingNCT06745895Not applicable
• Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCRecruitingNCT06745882Phase 2
• Digoxin Medulloblastoma StudyRecruitingNCT06701812Phase 2
• BCL2i CLAG-M in R/R Acute Myeloid LeukemiaRecruitingNCT06660368Phase 2
• Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic TherapyRecruitingNCT06660355Phase 2
• A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCCRecruitingNCT06597565Phase 2
• Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)RecruitingNCT06560398Not applicable
• Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCCRecruitingNCT06553885Phase 2
• Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCLRecruitingNCT06553872Phase 2
• Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRDRecruitingNCT06511882Phase 2
• Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal CancerRecruitingNCT06497569Not applicable
• Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant TherapyRecruitingNCT06435351Early Phase 1
• Exercise Prehabilitation for Locoregional Esophageal CancerRecruitingNCT06430346Not applicable
• Remote Exercise and Nutritional Prehabilitation for Pancreatic CancerRecruitingNCT06423963Not applicable
• Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)RecruitingNCT06423950
• Sequential Therapies Modeled on Evolutionary Dynamics for Breast CancerRecruitingNCT06409390Phase 2
• Rituximab and Zanubrutinib in Patients With Indolent B-cell LymphomasRecruitingNCT06350318Phase 2
• Avapritinib With Decitabine in Patients With SM-AHNRecruitingNCT06327685Phase 1
• Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)RecruitingNCT06305676
• Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced MelanomaRecruitingNCT06295159Phase 2
• Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesRecruitingNCT06238921Phase 1/2
• Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPCRecruitingNCT06193486Phase 1
• Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingNCT06144606Phase 2
• Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCCRecruitingNCT06137274Phase 2
• Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaRecruitingNCT06121180Phase 2
• Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCLRecruitingNCT06104592Phase 2
• Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid TumorsRecruitingNCT06047977Phase 1
• Outreach Core ActivitiesRecruitingNCT05832177
• Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell TherapyRecruitingNCT05757219Phase 2
• Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDSRecruitingNCT05746442Not applicable
• Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLCRecruitingNCT05681780Phase 1
• Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung CancerRecruitingNCT05665504
• Adaptive Therapy of Vismodegib in Advanced Basal Cell CarcinomaRecruitingNCT05651828Early Phase 1
• CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)RecruitingNCT05581030Phase 1
• CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AMLRecruitingNCT05558124Phase 1
• Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerRecruitingNCT05528133Phase 2
• Study of the Combination Dostarlimab With Niraparib In Patients With Penile CarcinomaRecruitingNCT05526989Phase 2
• DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast CancerRecruitingNCT05504707Phase 1
• Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & PertuzumabRecruitingNCT05325632Phase 2
• Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian CancerRecruitingNCT05316129Phase 1
• Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue SarcomaRecruitingNCT05301283Phase 2
• Study of Screening Brain MRIs in Stage IV Breast CancerRecruitingNCT05115474Phase 2
• Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AMLRecruitingNCT05024552Phase 1
• Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT04975152Phase 1
• SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesRecruitingNCT04923542Phase 1/2
• Intermittent Fasting for PancreatitisNot yet recruitingNCT04760847Not applicable
• Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaRecruitingNCT04741997Early Phase 1
• Generating Novel Therapeutic Strategies Based on Evolutionary Tumor BoardRecruitingNCT04343365
• Modifying Diet to Improve Gut MicrobiomeNot yet recruitingNCT03924778Not applicable
• PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresRecruitingNCT03495427Phase 2/3
• Aim 1: App for Reducing Cravings to SmokeCompletedNCT06923033Not applicableResults posted
• Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer SurvivorsCompletedNCT06476548Phase 1Results posted
• Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)CompletedNCT05177211Phase 2Results posted
• Automated Video-Assisted Smoking Treatment for People Living With HIVActive, not recruitingNCT05014282Not applicableResults posted
• Partnering With Food Bank to Provide Tobacco Treatment to Underserved SmokersCompletedNCT05004662Not applicableResults posted
• Adaptation Of An HPV Education Resource To Promote HPV VaccinationCompletedNCT04974619Results posted
• NPWT in Patients Undergoing Surgical Procedures for Management of GI MalignanciesCompletedNCT04955730Phase 2/3Results posted
• Motivating a Spectrum of Cancer Patients to Quit SmokingCompletedNCT04914000Not applicableResults posted
• Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell CarcinomaActive, not recruitingNCT04869137Phase 2Results posted
• Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T TherapyActive, not recruitingNCT04745559Phase 2Results posted
• CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AMLCompletedNCT04620681Phase 1/2Results posted
• Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma PatientsCompletedNCT04526730Phase 2Results posted
• Electronic Social Network Assessment Program (eSNAP) + Caregiver NavigatorCompletedNCT04268979Not applicableResults posted
• Barriers to Screening Breast MRI Utilization Among Patients at Elevated RiskCompletedNCT04257474Results posted
• Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCCTerminatedNCT04242173Phase 2Results posted
• Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic MalignanciesCompletedNCT04191187Phase 2Results posted
• TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT04163718Phase 2Results posted
• Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple MyelomaCompletedNCT04151667Phase 2Results posted
• Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep DisturbanceCompletedNCT04101526Not applicableResults posted
• Utilizing Augmented Reality as an Adjunct for Smoking CessationCompletedNCT04101422Not applicableResults posted
• Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue SarcomaCompletedNCT04052334Phase 1Results posted
• Study of T-VEC in Locally Advanced Cutaneous AngiosarcomaTerminatedNCT03921073Phase 2Results posted
• Aromatase Inhibitor and Durvalumab in Postmenopausal Breast CancerTerminatedNCT03874325Phase 2Results posted
• Avadomide (CC-122) in Combination With Nivolumab in Advanced MelanomaCompletedNCT03834623Phase 2Results posted
• Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking CessationCompletedNCT03734666Not applicableResults posted
• Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 ExpansionActive, not recruitingNCT03722407Phase 2Results posted

← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas